{"organizations": [], "uuid": "d32055174de094d6d8dbdc09c7dc55f7e7621029", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-alder-biopharmaceuticals-appoints/brief-alder-biopharmaceuticals-appoints-paul-b-cleveland-as-interim-ceo-idUSASC09T23", "country": "US", "domain_rank": 408, "title": "BRIEF-Alder Biopharmaceuticals Appoints Paul B. Cleveland As Interim CEO", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-20T22:23:00.000+02:00", "replies_count": 0, "uuid": "d32055174de094d6d8dbdc09c7dc55f7e7621029"}, "author": "", "url": "https://www.reuters.com/article/brief-alder-biopharmaceuticals-appoints/brief-alder-biopharmaceuticals-appoints-paul-b-cleveland-as-interim-ceo-idUSASC09T23", "ord_in_thread": 0, "title": "BRIEF-Alder Biopharmaceuticals Appoints Paul B. Cleveland As Interim CEO", "locations": [], "entities": {"persons": [{"name": "paul b. cle", "sentiment": "negative"}, {"name": "paul b. cleveland", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-alder biopharmaceuticals appoints paul b. cleveland as interim", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "alder biopharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 20, 2018 / 8:25 PM / Updated 8 minutes ago BRIEF-Alder Biopharmaceuticals Appoints Paul B. Cleveland As Interim CEO Reuters Staff 1 Min Read March 20 (Reuters) - Alder Biopharmaceuticals Inc: * ALDER BIOPHARMACEUTICALSÂ® APPOINTS PAUL B. CLEVELAND AS INTERIM PRESIDENT AND CHIEF EXECUTIVE OFFICER Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-20T22:23:00.000+02:00", "crawled": "2018-03-20T22:35:43.213+02:00", "highlightTitle": ""}